WIRE — Malawi has officially introduced a new twice-yearly injectable HIV prevention drug, marking what health officials describe as a significant milestone in the countrys effort to end AIDS as a public health threat. The drug, Lenacapavir, was launched at Area 25 Community Hospital in Lilongwe on Thursday. It joins oral PrEP and a two-monthly injectable alternative, The post Malawi launches twice-yearly HIV injection in push to cut new infections below 4,000 by 2030 appeared first on Malawi News | Breaking News, Politics, Business & Sports | Nyasa Times.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.